These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2307503)

  • 1. Antipyrine clearance: prognostic marker for obstructive jaundice.
    Nazareth HM; Rege NN; Nayak VK; Desai NK; Someshwar V; Dahanukar SA; Bapat RD
    Indian J Gastroenterol; 1990 Jan; 9(1):63-6. PubMed ID: 2307503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipyrine elimination in patients with obstructive jaundice: a predictor of outcome.
    McPherson GA; Benjamin IS; Boobis AR; Blumgart LH
    Am J Surg; 1985 Jan; 149(1):140-3. PubMed ID: 3966630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine elimination test as a guideline for selecting patients for transhepatic biliary drainage.
    Ramesh VS; Kochhar R; Garg SK; Wig JD; Gupta NM
    J Gastroenterol Hepatol; 1990; 5(3):219-22. PubMed ID: 2103402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipyrine elimination as a dynamic test of hepatic functional integrity in obstructive jaundice.
    McPherson GA; Benjamin IS; Boobis AR; Brodie MJ; Hampden C; Blumgart LH
    Gut; 1982 Sep; 23(9):734-8. PubMed ID: 7106619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bilirubin after surgery for obstructive jaundice.
    Little JM; Robotin M
    Aust N Z J Surg; 1986 Jan; 56(1):35-7. PubMed ID: 3461768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic functional reserve in patients with obstructive jaundice: an assessment by the redox tolerance test.
    Tsubono T; Tsukada K; Hatakeyama K
    Am J Surg; 1995 Mar; 169(3):300-3. PubMed ID: 7879830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we do away with PTBD?
    Bapat RD; Rege NN; Koti RS; Desai NK; Dahanukar SA
    HPB Surg; 1995; 9(1):5-11. PubMed ID: 8857447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study.
    Mann DV; Lam WW; Magnus Hjelm N; So NM; Yeung DK; Metreweli C; Lau WY
    Gut; 2002 Jan; 50(1):118-22. PubMed ID: 11772978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative percutaneous transhepatic biliary decompression lowers operative morbidity in patients with obstructive jaundice.
    Denning DA; Ellison EC; Carey LC
    Am J Surg; 1981 Jan; 141(1):61-5. PubMed ID: 6779653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between rifamycin-SV (R-SV) related hyperbilirubinaemia and antipyrine clearance as a new test of liver function in cirrhosis.
    Persico M; Romano M; Villano N; Montella F; Gentile S
    Eur J Clin Invest; 1994 Mar; 24(3):201-4. PubMed ID: 8033955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative biliary drainage in obstructive jaundice.
    Kawarada Y; Higashiguchi T; Yokoi H; Vaidya P; Mizumoto R
    Hepatogastroenterology; 1995; 42(4):300-7. PubMed ID: 8586359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of metabolic efficiency of the liver in patients with psoriasis by the antipyrine test].
    Bienias L; Czarnecki M; Kaszuba A; Ruszczak Z; Kozłowska M; Bednarowicz G; Drobnik G
    Przegl Dermatol; 1990; 77(5):301-6. PubMed ID: 2270292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine kinetics in patients with primary biliary cirrhosis.
    von Moltke LL; Abernethy DR; Kaplan MM; Greenblatt DJ
    J Clin Pharmacol; 1993 Jan; 33(1):75-7. PubMed ID: 8429118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of functional liver reserve in patients before cardiac surgery using antipyrine plasma clearance test.
    Takeda M; Furuse A; Kawauchi M; Kotsuka Y; Takamoto S
    J Cardiovasc Surg (Torino); 1999 Dec; 40(6):817-23. PubMed ID: 10776711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression.
    Coverdale SA; Samarasinghe DA; Lin R; Kench J; Byth K; Khan MH; Crewe E; Liddle C; George J; Farrell GC
    Am J Gastroenterol; 2003 Jun; 98(6):1384-90. PubMed ID: 12818285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma human hepatocyte growth factor concentrations in patients with biliary obstruction.
    Kimura F; Miyazaki M; Suwa T; Sugiura T; Shinoda T; Itoh H; Ambiru S; Shimizu H; Nakagawa K
    J Gastroenterol Hepatol; 2000 Jan; 15(1):76-82. PubMed ID: 10719751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of the antipyrine test in assessing liver function in patients with insulin-dependent diabetes mellitus].
    Khanina EV; Gorshteĭn ES; Michurina SP
    Probl Endokrinol (Mosk); 1990; 36(3):14-5. PubMed ID: 2395825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis.
    Wensing G; Hoffmann K; Heidemann HT
    Z Gastroenterol; 1993 Jan; 31(1):15-9. PubMed ID: 8447150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose methotrexate treatment and liver function in patients with osteosarcoma.
    Fabbri A; Motta E; Ferrari S; Longhi C; Marchi E; Bacci G; Figus E; Marchesini G
    J Intern Med; 1994 Aug; 236(2):209-14. PubMed ID: 8046321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.